Effect of the Erchonia® HLS™ for the Relief of Tinnitus Symptoms

Exclusion Criteria

• •Objective tinnitus
• •Atonal, pulsatile, intermittent, or occasional tinnitus
• •Severe or profound hearing loss in one or both ears
• •Current or prior surgically removed acoustic neuroma
• •Consistent use of any of the following drugs known to cause or increase tinnitus (primarily ototoxins) within the past 30 days:
• •NSAIDS (motrin, naproxen, relafen, etc) aspirin (exceeding 300mg per day) and other salicylates Lasix and other "loop" diuretics "mycin" antibiotics such as vancomycin quinine and related drugs Chemotherapy agents such as cis-platin
• •Acute or chronic vertigo/dizziness
• •Ménière's disease
• •Prior stapendectomy
• •Prior mastoidectomy
• •Auditory nerve tumor (acoustic neuroma), current or surgically removed in the past
• •Active infection/wound/external trauma to the areas to be treated with the laser
• •Medical, physical or other contraindications for, or sensitivity to, light therapy
• •Pregnant, breast feeding, or planning pregnancy prior to the end of study participation
• •Developmental disability or cognitive impairment that in the opinion of the investigator would preclude adequate comprehension of the informed consent form and/or ability to record the necessary study measurements